Peyronie’s Disease. Induratio penis plastica
Conditions
Interventions
Intervention 1: Intervention group: In the treatment group for 6 weeks , two sessions in a week,1064 laser with a power of 0.5 watts and a dose of 50 jules per square centimeter in an area of 1 centim
Treatment - Other
Placebo
Intervention group: In the treatment group for 6 weeks , two sessions in a week,1064 laser with a power of 0.5 watts and a dose of 50 jules per square centimeter in an area of 1 centimeter square with
Control group: The only standard treatment for verapamil injection is done and the laser probe is placed on the plaque with red light only.
Sponsors
Vice chancellor for research,Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion Criteria: All Patients with Peyronie's Disease; aged 18 years and over; have at least Peyronie's Disease for 6 months ; Exclusion criteria: Patients with a Peyronie's Disease and receive multiple treatments; Skin disorder in the penis; History of Inflammatory diseases of the skin; uncontrolled hypertension; history of heart attacks in the last one month; patients with acute phase or released fibrosis plaque during the penis; patients who are not satisfied to entering the study;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plaque size. Timepoint: One month and three months after the end of treatment. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Farzad Allameh
Laser Application Research Center in Medical Science
Outcome results
None listed